Selecting the correct vendors to support your UX project is critical to success. From facilities to recruiting, knowing the right questions to ask, budget constraints, and client needs and expectations will make the selection process smooth and painless.
Back to team page
Katrina Orlov
Senior UX Researcher
Katrina’s dual background in art and science has honed her ability to think creatively and with strong attention to detail. Katrina has led and supported UX research and design projects in the consumer product, e-commerce, and healthcare spaces. To each project she brings a wide range of experience in ethnography, contextual inquiry, diary studies, focus groups, individual interviews, expert reviews, usability studies, rapid iterative design testing, and ideation workshopping. Katrina has an MS in Human Factors in Information Design from Bentley University.




Bold facts
Learn more about

Something unique about you summed up in one sentence

Your favorite part of working at Bold Insight

In your spare time (or if you had spare time), you would absolutely do this:

How long have you been in the UX field?

You cannot start the day without doing this:

Your ultimate celebrity dinner party guest list would include:

Long-term personal or professional goal?

Your favorite city in the world is...and why?
Read our team’s latest bold insights
Reclassifying diabetes: 3 implications for product design
Recent research suggests that reclassifying diabetes may allow for the development of more targeted diabetes treatments. This could present opportunities to design these treatments to maximize patient safety and experience.
Designing your POS so it’s not a POS
Regardless of whether the interface is intended to be used by a customer (novice) or an employee (expert), the key is to ensure that the POS interface is designed for the intended audience. To do this, organizations should engage users throughout the design process.
FDA’s digital health precertification program emphasizes importance of post-market surveillance
Finding efficient ways to leverage post-market surveillance data to inform product development at an institutional level will be key for SaMD manufacturers seeking FDA precertification.